Besides, mTOR inhibition can also act synergistically with radiation therapy to reinforce the anti-angiogenic effects and suppress HNSCC tumor growth in xenograft models [272,273]. The gene discussed is MTOR; the disease is head and neck squamous cell carcinoma.